Abstract
Human papillomavirus (HPV) infection represents the most diffuse sexually transmitted disease of the lower genital tract, with an estimated risk of infection in the general population of 80% over the course of the lifetime [...]
Subject
Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology
Reference29 articles.
1. Epidemiology and burden of HPV-related disease;Serrano;Best Pract. Res. Clin. Obstet. Gynaecol.,2018
2. Curado, M.P., Edwards, B., Shin, H.R., Storm, H., Ferlay, J., Heanue, M., and Boyle, P. (2008). Cancer Incidence in Five Continents, IARC Press.
3. Interaction of human papillomaviruses with the host immune system: A well evolved relationship;Frazer;Virology,2009
4. Gardella, B., Pasquali, M.F., La Verde, M., Cianci, S., Torella, M., and Dominoni, M. (2022). The Complex Interplay between Vaginal Microbiota, HPV Infection, and Immunological Microenvironment in Cervical Intraepithelial Neoplasia: A Literature Review. Int. J. Mol. Sci., 23.
5. Estimates of Incidence and Mortality of Cervical Cancer in 2018: A Worldwide Analysis;Arbyn;Lancet Glob. Health,2020